Shingles vaccination reduces dementia risk, researchers reported on June 15, 2026 in the Annals of Internal Medicine. “Receipt of RZV [recombinant shingles vaccine] during admission to a skilled-nursing… read more.
Pediatric flu vaccines significantly reduce the number of childhood cases of influenza, new research from Harvard Medical School confirms. The findings, published on June 1 in JAMA Pediatrics, show… read more.
The European Medicines Agency (EMA) has unveiled a new communications effort designed to inform evidence-based decision-making. Vaccine Essentials offers healthcare professionals accessible summaries of how the quality, safety… read more.
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life, according to a new Cornell University study. The paper,… read more.
Novartis announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and young infants weighing from 2… read more.
A study in Health Economics uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed… read more.
Flu vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people who get infected after getting the vaccine, according to research published in… read more.
Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for… read more.
People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get… read more.
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026. Presentations include three-year follow-up data from patients receiving a one-time… read more.
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting FRAMINGHAM, Mass. & SALISBURY, England–(BUSINESS WIRE)–Feb. 12, 2026– KalVista Pharmaceuticals, Inc…. read more.
Researchers have shown for the first time that maternal antibodies are found not only in the blood of newborns, but also in the nasal mucosa. The international study,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
